82 FR 1340 - Agency Forms Undergoing Paperwork Reduction Act Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 3 (January 5, 2017)

Page Range1340-1341
FR Document2016-31967

Federal Register, Volume 82 Issue 3 (Thursday, January 5, 2017)
[Federal Register Volume 82, Number 3 (Thursday, January 5, 2017)]
[Notices]
[Pages 1340-1341]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-31967]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-17-16AWE]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be

[[Page 1341]]

collected; (d) Minimize the burden of the collection of information on 
those who are to respond, including through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and (e) Assess information 
collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

    Information Collection for Tuberculosis Data from Referring 
Entities to CureTB--Existing Collection in use without an OMB Control 
Number--National Center for Emerging Zoonotic and Infectious Diseases 
(NCEZID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    CDC is assuming the administration of the CureTB program from the 
San Diego Public Health Department. This transition is occurring 
because the activities align with a national disease control 
perspective, CDC can better leverage internal resources and 
international partnerships with foreign public health authorities, and 
key CureTB management staff transitioned from San Diego County Public 
Health to CDC.
    CureTB works with domestic and international programs to protect 
the U.S. public by preventing the global development of drug resistance 
and reducing disease transmission and importation of infectious TB. 
These goals are accomplished through CureTB referral and continuity of 
care services for mobile TB patients.
    Lack of treatment adherence and inappropriate selection of 
medications are prime reasons for the continued emergence and spread of 
resistant strains. To combat this, CureTB assures patients understand 
how to remain adherent despite moving between nations and provides 
information to the health care team that will be continuing care, about 
each patient's TB strain and tailored medication regimen. CureTB 
gathers demographic and clinical information for each patient, and 
connects that individual to care through provision of accurate 
information about how to locate the correct downstream provider and 
assurance that real-time information is given directly to medical 
providers and public health authorities in receiving nations.
    The respondents are nurse practitioners, registered nurses, and 
physicians working for organizations within the United States and other 
countries who provide diagnostic and treatment services to individuals 
affected by TB. The organizations are primarily state and local health 
departments, but include immigration centers, correctional facilities, 
and foreign national TB programs. Individual TB patients may also be 
respondents if critical clinical or contact information is missing from 
their referral and CureTB follows-up with them to fill-in gaps to 
complete the referral service. All 50 US states and territories may 
refer TB patients to the CureTB program. To date, CureTB has also 
received referrals from Mexico and Guatemala.
    Registered nurses or nurse practitioners will submit CureTB 
referral forms as they request referral services. The number of 
referrals varies widely between respondents.
    CDC's CureTB program will also continue working with our public 
health partners in notifications and referrals for contacts of TB 
cases. This is a lesser used function of CureTB, but burden is included 
below. These respondents are registered nurses or nurse practitioners 
working in health departments.
    To ensure adequate referral to treatment occurs, CDC CureTB may 
need to follow-up with an individual to complete missing data fields 
concerning clinical or contact information. This is done to ensure 
continuity of care. Therefore, individuals with TB are also respondents 
in this information collection
    Finally, CDC staff in the CureTB program also contact the new 
treating physicians to determine patient outcomes using CureTB 
Clinician Public Health Department Follow-up Script. The physicians are 
generally contacted every two months over the course of standard six-
month TB treatment, for a total of three follow-up contacts per 
patient.
    There are no costs to respondents other than the time required to 
complete the referral documents and respond to CDC requests for TB 
patient outcomes. The total burden requested is 558 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
        Type of respondents                   Form name             respondents   responses  per   response  (in
                                                                                     respondent       hours)
----------------------------------------------------------------------------------------------------------------
Registered Nurses/Nurse              CureTB Transnational                    100               5           30/60
 Practitioners.                       Notification.
TB patients........................  CureTB Transnational                    100               1            5/60
                                      Notification.
Registered Nurses/Nurse              CureTB Contact/Source                    20               5           30/60
 Practitioners.                       Investigation (CI/SI)
                                      Notification.
TB treating physicians.............  Clinician Public Health                 500               3           10/60
                                      Department Follow-up
                                      Script.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-31967 Filed 1-4-17; 8:45 am]
 BILLING CODE 4163-18-P


Current View
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation82 FR 1340 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR